Synergy Life Science Partners

Synecor LLC is a medical device company based in Durham, North Carolina, with additional locations in California and North Carolina. Founded in 2000 by Dr. Richard Stack, the company emerged from collaborative relationships in the field of interventional cardiology. Synecor specializes in developing innovative medical device technologies across various specialties, including obesity and spine therapeutics. The company focuses on creating minimally invasive device-based treatments, bioerodible vascular stent platforms for coronary artery disease, and solutions for managing arrhythmias. Additionally, Synecor is advancing a technology platform designed to access and treat the gastrointestinal system through natural orifices. By addressing unmet medical needs, Synecor aims to offer effective treatment options that enable patients to begin their care promptly, thereby improving the likelihood of successful outcomes.

NeuroTronik, spun out of medical technology incubator Synecor, is developing a medical device that could take the place of drugs currently used to heart failure. Read more about the company's technology,

Inspire Medical Systems, Inc. is a medical technology company dedicated to developing and commercializing minimally invasive solutions for patients suffering from obstructive sleep apnea (OSA). Founded in 2007 and headquartered in Golden Valley, Minnesota, the company specializes in innovative implantable neurostimulation technologies. Its primary product, the Inspire system, utilizes a proprietary Upper Airway Stimulation (UAS) therapy that provides a safe and effective treatment for moderate to severe OSA. This technology leverages established principles from cardiac pacing and neurostimulation to deliver mild hypoglossal nerve stimulation, which helps maintain an open airway by continuously monitoring the patient's breathing. Inspire Medical Systems operates primarily in the United States and Europe, generating most of its revenue from the U.S. market.

Inspire Medical Systems, Inc. is a medical technology company dedicated to developing and commercializing minimally invasive solutions for patients suffering from obstructive sleep apnea (OSA). Founded in 2007 and headquartered in Golden Valley, Minnesota, the company specializes in innovative implantable neurostimulation technologies. Its primary product, the Inspire system, utilizes a proprietary Upper Airway Stimulation (UAS) therapy that provides a safe and effective treatment for moderate to severe OSA. This technology leverages established principles from cardiac pacing and neurostimulation to deliver mild hypoglossal nerve stimulation, which helps maintain an open airway by continuously monitoring the patient's breathing. Inspire Medical Systems operates primarily in the United States and Europe, generating most of its revenue from the U.S. market.

iRhythm Technologies is a digital healthcare company specializing in ambulatory cardiac monitoring solutions. It offers the Zio Patch, a wire-free, wearable biosensor that records ECG data for up to 14 days, aiding physicians in diagnosing arrhythmias efficiently.

Aptus Endosystems, Inc. is a medical device company focused on developing advanced solutions for endovascular aneurysm repair (EVAR). Founded in 2002 and based in Sunnyvale, California, the company has created innovative technologies such as the Heli-FX EndoAnchor system, which provides a durable method for treating abdominal and thoracic aortic aneurysms. This system employs unique helical staple technology that allows for independent fixation of endografts, mimicking the precision of open surgical suturing while facilitating minimally invasive procedures. Additionally, Aptus Endosystems offers the Aptus TourGuide, a steerable sheath designed to enhance access and delivery of peripheral vascular products. The company's products are distributed in key markets including the United States and several European countries, and the Aptus Endovascular AAA Repair Systems hold CE Marking for distribution within the European Union.

Inspire Medical Systems, Inc. is a medical technology company dedicated to developing and commercializing minimally invasive solutions for patients suffering from obstructive sleep apnea (OSA). Founded in 2007 and headquartered in Golden Valley, Minnesota, the company specializes in innovative implantable neurostimulation technologies. Its primary product, the Inspire system, utilizes a proprietary Upper Airway Stimulation (UAS) therapy that provides a safe and effective treatment for moderate to severe OSA. This technology leverages established principles from cardiac pacing and neurostimulation to deliver mild hypoglossal nerve stimulation, which helps maintain an open airway by continuously monitoring the patient's breathing. Inspire Medical Systems operates primarily in the United States and Europe, generating most of its revenue from the U.S. market.

iRhythm Technologies is a digital healthcare company specializing in ambulatory cardiac monitoring solutions. It offers the Zio Patch, a wire-free, wearable biosensor that records ECG data for up to 14 days, aiding physicians in diagnosing arrhythmias efficiently.

iRhythm Technologies is a digital healthcare company specializing in ambulatory cardiac monitoring solutions. It offers the Zio Patch, a wire-free, wearable biosensor that records ECG data for up to 14 days, aiding physicians in diagnosing arrhythmias efficiently.

iRhythm Technologies is a digital healthcare company specializing in ambulatory cardiac monitoring solutions. It offers the Zio Patch, a wire-free, wearable biosensor that records ECG data for up to 14 days, aiding physicians in diagnosing arrhythmias efficiently.

Asensus Surgical is a medical device company focused on enhancing minimally invasive surgery through digital laparoscopy. By digitizing the interface between surgeons and patients, the company incorporates advanced technologies such as augmented intelligence, connectivity, and robotics into surgical procedures. Their flagship product, the Senhance Surgical System, is notable for being the first machine vision system designed for robotic surgery. This system is supported by the Intelligent Surgical Unit, which facilitates augmented intelligence in surgery. Asensus Surgical aims to address various clinical, cognitive, and economic challenges faced in surgical practices, ultimately improving patient outcomes through innovative solutions in digital laparoscopy.

BaroSense is focused on developing and commercializing innovative medical devices aimed at addressing obesity, a significant healthcare challenge in the United States. The company aims to provide safe, simple, and effective alternatives to surgical treatments for obesity, catering to individuals who require assistance beyond traditional dieting methods and wish to avoid extensive and irreversible surgical options. BaroSense's product offerings include minimally invasive therapeutic procedures and devices, such as a trans-oral endoscopic restrictive implant system, designed to facilitate weight loss in a less invasive manner.

Oraya Therapeutics focuses on developing noninvasive, robotically controlled treatments for inflammatory and neovascular diseases of the eye. The company is currently testing its first application of the IRay system, which aims to provide innovative solutions for eye-related conditions. By leveraging advanced technology, Oraya Therapeutics seeks to improve patient outcomes and enhance the management of ocular diseases.

Inspire Medical Systems, Inc. is a medical technology company dedicated to developing and commercializing minimally invasive solutions for patients suffering from obstructive sleep apnea (OSA). Founded in 2007 and headquartered in Golden Valley, Minnesota, the company specializes in innovative implantable neurostimulation technologies. Its primary product, the Inspire system, utilizes a proprietary Upper Airway Stimulation (UAS) therapy that provides a safe and effective treatment for moderate to severe OSA. This technology leverages established principles from cardiac pacing and neurostimulation to deliver mild hypoglossal nerve stimulation, which helps maintain an open airway by continuously monitoring the patient's breathing. Inspire Medical Systems operates primarily in the United States and Europe, generating most of its revenue from the U.S. market.

iRhythm Technologies is a digital healthcare company specializing in ambulatory cardiac monitoring solutions. It offers the Zio Patch, a wire-free, wearable biosensor that records ECG data for up to 14 days, aiding physicians in diagnosing arrhythmias efficiently.

Oraya Therapeutics focuses on developing noninvasive, robotically controlled treatments for inflammatory and neovascular diseases of the eye. The company is currently testing its first application of the IRay system, which aims to provide innovative solutions for eye-related conditions. By leveraging advanced technology, Oraya Therapeutics seeks to improve patient outcomes and enhance the management of ocular diseases.

Asensus Surgical is a medical device company focused on enhancing minimally invasive surgery through digital laparoscopy. By digitizing the interface between surgeons and patients, the company incorporates advanced technologies such as augmented intelligence, connectivity, and robotics into surgical procedures. Their flagship product, the Senhance Surgical System, is notable for being the first machine vision system designed for robotic surgery. This system is supported by the Intelligent Surgical Unit, which facilitates augmented intelligence in surgery. Asensus Surgical aims to address various clinical, cognitive, and economic challenges faced in surgical practices, ultimately improving patient outcomes through innovative solutions in digital laparoscopy.

BaroSense is focused on developing and commercializing innovative medical devices aimed at addressing obesity, a significant healthcare challenge in the United States. The company aims to provide safe, simple, and effective alternatives to surgical treatments for obesity, catering to individuals who require assistance beyond traditional dieting methods and wish to avoid extensive and irreversible surgical options. BaroSense's product offerings include minimally invasive therapeutic procedures and devices, such as a trans-oral endoscopic restrictive implant system, designed to facilitate weight loss in a less invasive manner.

iRhythm Technologies is a digital healthcare company specializing in ambulatory cardiac monitoring solutions. It offers the Zio Patch, a wire-free, wearable biosensor that records ECG data for up to 14 days, aiding physicians in diagnosing arrhythmias efficiently.

InnerPulse, Inc. develops technology, devices, software protocols, and procedures to transform the treatment of cardiac arrhythmias. It offers invasive treatment that enables physicians to implant the life-saving Percutaneous Implantable Cardioverter Defibrillator within the patient's vascular system. InnerPulse, Inc. was formerly known as Interventional Rhythm Management, Inc.